In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.


The free consultation period for this content is over.

It is now only available year-round to EAPC Ivory (& above) Members, Fellows of the ESC and Young combined Members

Sex- and age-specific associations between cardiorespiratory fitness, CVD morbidity and all-cause mortality in 316.137 Swedish adults

Session Rapid Fire Session 2

Speaker Associate Professor Elin Ekblom-Bak

Congress : EuroPrevent 2019

  • Topic : preventive cardiology
  • Sub-topic : Physical Inactivity and Exercise
  • Session type : Rapid Fire Abstracts
  • FP Number : 366

Authors : E Ekblom-Bak (Stockholm,SE), B Ekblom (Stockholm,SE), J Soderling (Stockholm,SE), M Borjesson (Gothenburg,SE), V Blom (Stockholm,SE), LV Kallings (Stockholm,SE), E Hemmingsson (Stockholm,SE), G Andersson (Stockholm,SE), P Wallin (Stockholm,SE), O Ekblom (Stockholm,SE)

15 views

Authors:
E Ekblom-Bak1 , B Ekblom1 , J Soderling2 , M Borjesson3 , V Blom1 , LV Kallings1 , E Hemmingsson1 , G Andersson4 , P Wallin4 , O Ekblom1 , 1The Swedish School of Sport and Health Sciences - Stockholm - Sweden , 2Karolinska Institute - Stockholm - Sweden , 3University of Gothenburg - Gothenburg - Sweden , 4HPI Health Profile Institute - Stockholm - Sweden ,

Citation:

Introduction
Little is known whether sex- and age differences in cardiorespiratory fitness translates into corresponding differences in sex- and age-related risk associations with cardiovascular disease (CVD) morbidity and all-cause mortality.

Purpose 
To investigate the sex- and age-specific associations, and the shape of the associations with a possible existing plateau, between cardiorespiratory fitness and CVD morbidity and all-cause mortality in a large sample of men and women of different ages free from CVD at baseline.

Methods 
316.137 participants aged 18-74 years (45% women) who participated in a nationwide occupational health service screening between 1995 and 2015 were included. Cardiorespiratory fitness was expressed as relative maximal oxygen uptake (VO2max, in ml·min-1·kg-1), and estimated using a submaximal cycle test. Incident cases of a first-time CVD event and death from any cause were ascertained through the national in-hospital registry and the Swedish national cause of death registry.

Results
Age-adjusted CVD morbidity and all-cause mortality incidence rates were inversely related to VO2max from low to high levels in both men and women and in all age-groups, with men, higher age and lower VO2max levels having higher incidence rates compared to their counterparts (Figure 1). Only in older men were the risk reduction less pronounced in the higher end of the VO2max spectrum, with a possible plateau effect (see figure). The risk (95% CI) for all-cause mortality and CVD morbidity decreased with 2.8% (2.3%-3.3%) and 3.2% (2.8%-3.5%) per increase in ml·min-1·kg-1 in the total population, and were greater in men (3.4% vs. 2.0%, p=0.003), in older ages (18-49 y: 2.4% vs. 50-59 y: 2.9% vs. 60-74y: 3.8%, non-significant between groups) and in participants with VO2max below median (4.7% vs. 1.4%, p<0.001) for all-cause mortality. Corresponding risk reductions for CVD morbidity were also higher in participants with VO2max below median (3.5% vs. 1.7%, p=0.004), but greater in young vs. old ages (18-49 y: 3.5% vs. 50-59 y: 3.1% vs. 60-74y: 2.4%, non-significant between groups) and similar in men compared to women (3.1% vs. 3.4%, non-sigificant). 

Conclusions
In this large cohort of the Swedish working population, CVD morbidity and all-cause mortality were inversely related to cardiorespiratory fitness in both men and women and in all age-groups. Preventive actions to increase cardiorespiratory fitness is a clear public health priority, especially for vulnerable groups.

The free consultation period for this content is over.

It is now only available year-round to EAPC Ivory (& above) Members, Fellows of the ESC and Young combined Members



Based on your interests

Three reasons why you should become a member

Become a member now
  • 1Access your congress resources all year-round on the New ESC 365
  • 2Get a discount on your next congress registration
  • 3Continue your professional development with free access to educational tools
Become a member now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are